Congenital cytomegalovirus (CMV) infections: hats off to Alabama.
Prober
Charles G
CG
Enright
Andrea M
AM
D000407:Alabama / Q000453:epidemiology; D000998:Antiviral Agents / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000188:drug therapy / Q000453:epidemiology*; D015774:Ganciclovir / Q000009:adverse effects; D006319:Hearing Loss, Sensorineural / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000706:statistics & numerical data; D008607:Intellectual Disability / Q000453:epidemiology; D008831:Microcephaly / Q000453:epidemiology; D009468:Neuromuscular Diseases / Q000453:epidemiology; D009503:Neutropenia / Q000139:chemically induced; D009896:Optic Atrophy / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D013921:Thrombocytopenia / Q000139:chemically induced
D000998:Antiviral Agents; D015774:Ganciclovir